Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients

BACKGROUND: Lactate dehydrogenase (LDH) represents a predictive factor in colorectal cancer patients treated with the angiogenesis inhibitor PTK/ZK. We explored the role of pre-treatment LDH serum levels in colorectal cancer patients receiving first-line bevacizumab. METHODS: Metastatic colorectal c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Scartozzi, M, Giampieri, R, Maccaroni, E, Del Prete, M, Faloppi, L, Bianconi, M, Galizia, E, Loretelli, C, Belvederesi, L, Bittoni, A, Cascinu, S
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2012
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3305976/
https://ncbi.nlm.nih.gov/pubmed/22315053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2012.17
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados